Goldman Sachs Lifts PT on Walgreen (WAG), Maintains Top Rating Post Q1 Noise
Tweet Send to a Friend
Get Alerts WAG Hot Sheet
Price: $50.62 -0.55%
Rating Summary:
14 Buy, 7 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
14 Buy, 7 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade WAG Now!
Goldman Sachs raised its price target on Walgreen (NYSE: WAG) from $42 to $44 while reiterating its Conviction Buy List rating following recent Q1 results which, according to the firm, "demonstrated solid underlying trends, supported by building reclamation of scripts lost during its impasse with ESRX, well controlled expenses given the breadth of the firm’s initiatives, and a spike in gross margin supported by generics."
The firm noted that the delay in reporting its share of earnings from Alliance Boots created headline noise, reducing earnings, but that income should be reclaimed next year. However, all the pieces are in place for the company to deliver solid results over the balance of its fiscal year, and they expect a strong December sales update given ongoing script reclamation and a recent pick-up in flu incidence.
The firm trimmed its FY13 EPS estimate from $3.34 to $3.25 on the change in timing of Alliance Boots earnings, a slightly higher share count, and lower LIFO add-back given greater generic deflation.
For an analyst ratings summary and ratings history on Walgreen click here. For more ratings news on Walgreen click here.
Shares of Walgreen closed at $36.53 yesterday, with a 52 week range of $28.53-$37.75.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm noted that the delay in reporting its share of earnings from Alliance Boots created headline noise, reducing earnings, but that income should be reclaimed next year. However, all the pieces are in place for the company to deliver solid results over the balance of its fiscal year, and they expect a strong December sales update given ongoing script reclamation and a recent pick-up in flu incidence.
The firm trimmed its FY13 EPS estimate from $3.34 to $3.25 on the change in timing of Alliance Boots earnings, a slightly higher share count, and lower LIFO add-back given greater generic deflation.
For an analyst ratings summary and ratings history on Walgreen click here. For more ratings news on Walgreen click here.
Shares of Walgreen closed at $36.53 yesterday, with a 52 week range of $28.53-$37.75.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- UPDATE: Raymond James Downgrades Gevo, Inc. (GEVO) to Market Perform
- Adobe (ADBE) Posts Positive Creative Cloud Subscriber Surprise in Q2 - Jefferies
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Goldman Sachs Conviction Buy List, Goldman Sachs, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
